Immunogen, Inc. (IMGN) Posts Narrower than Expected Q2 Loss
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
EPS Growth %: +100.0%
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
BFRI, HCTI, IMPM, More
EPS Growth %: +100.0%
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $5.43 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Adverum Biotechnologies (ADVM) Tops Q4 EPS by 11c
- Tango Therapeutics, Inc. (TNGX) Misses Q4 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!